ArticleEClinicalMedicine2024

Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I study.

Suying Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.